Escamilla GG

Language: Spanish
References: 13
Page: 73-75
PDF size: 114.53 Kb.

Text Extraction

No Abstract

REFERENCES

1. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. USA: Cold Sping Harbor Laboratory Press; 1989.

2. 2. Dood R Germ. Geles, and genomes by in blood safety in the new millennium by Strammer Sussan L. Second edition. Maryland; Bethesda: AABB; 2001 p. 97-118.

3. 3. Tegtmeier GE, Parks LH, Blosser JK. Hepatitis markers in blood donors with a history of hepatitis or jaundice. Transfusion 1991:31:64S.

4. 4. Blumberg BS, Gerstleuy BJS, Hungerford DA. A FERUM antigen (Australia antigen) in Down’s syn-drome, leukemia and hepatitis. Ann Intern Med 1967; 66:924-928.

5. 5. Ling CM, Overby LR. Relevance of hepatitis B virus antigen as revealed by direct radioimmune assay with 125-I-antibody. J Immunol 1972;109:834-840.

6. 6. Aach RD, Szmuness W.Mosley JW. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The Transfusion-Transmitted Viruses Study. N Engl J Med 1981;304: 989-994.

7. 7. Koziol DE, Hollan PV, Alling DW, Antibody to hepaitis B core antigen as a paradoxical marker for non-a non-b hepatitis agents in donated blood. Ann Intern Med 1986;104: 488-495.

8. 8. Choo QL, Kuo G, Wiener AJ. Isolation of a cDNA clone derived from a blood-borne non-A non-B hepatitis genome. Science 1989; 244:362-364.

9. 9. Kuo G, Choo QL, Alter HJ. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.

10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Sping Harbor Laboratory. USA: Press; 1989

11. Flanagan P, Barbara J. PCR Testing of plasma pools: from concept to reality. Trans Med Rev 1999;13:164-176.

12. Strramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian Blood supply. Transfusion 2000;40:1164-1167.

13. Murthy KK, Henrard DR, Eichberg JW. Redefining the HIV infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission. Transfusion 199;39:688-693.